SII-Novavax Vaccine Generates Immunity Response To Omicron Variant; Companies Agreed To Send Over 1.1 Bn Doses to COVAX
SII-Novavax Inc’s COVID-19 vaccine Covovax, triggers an immune response against the Omicron variant, and in addition, booster dose generates further immune resistance to this highly contagious variant, the US biotechnology…